Entero Healthcare Solutions Limited (NSE: ENTERO), ISIN INE010601016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ENTERO last traded at ₹1225.00 (+0.03%), with a 52-week range of ₹944.00 to ₹1390.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 52.40%, FIIs 4.37%, DIIs 15.48%, mutual funds 8.97%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.